On Monday, Glenmark Pharmaceuticals announced a recall, to the patient level, of more than 100 batches of potassium chloride ER 750mg capsules. The recall is due to a dissolution problem that may cause hyperkalemia and may lead to irregular heartbeat, which can cause cardiac arrest. Pharmacies complying with the Drug Supply Chain Security Act should be able to access their tracing data to determine if they purchased an affected lot. Pharmacies should work with patients and prescribers to minimize treatment interruption but discontinue using affected product. For more details, including contact information for consumers to get return instructions, visit the FDA recall page. For more information about compliance with DSCSA, including a technology solution that helps you manage drug tracing data and recall alerts, visit ncpa.org/dscsa-360.
NCPA
